MétaCan
Menu
Back to cohort
Record W4411079463 · doi:10.1016/j.kint.2025.05.016

Chemical chaperone 4-phenylbutyrate treatment alleviates the kidney phenotype in a mouse model of Alport syndrome with a pathogenic variant in Col4a3

2025· article· en· W4411079463 on OpenAlexfundno aff
Pavlos Ioannou, Christoforos Odiatis, Rania Hadjisavva, Kyriaki I. Antoniadou, Myrtani Pieri, Apostolos Malatras, Gregory Papagregoriou, Paris A. Skourides, Martina Samiotaki, Matija Horaček, Danica Galešić Ljubanović, Kostas Stylianou, Constantinos Deltas

Bibliographic record

VenueKidney International · 2025
Typearticle
Languageen
FieldMedicine
TopicCell Adhesion Molecules Research
Canadian institutionsnot available
FundersAtlantic Salmon FederationH2020 Spreading Excellence and Widening ParticipationResearch Promotion FoundationResearch and Innovation FoundationKidney Foundation of CanadaUniversity of CyprusHorizon 2020 Framework ProgrammeAlport Syndrome Foundation
KeywordsPhenylbutyrateAlport syndromePhenotypeMedicineChemical chaperoneGlomerulonephritisKidneyBiologyImmunologyInternal medicineGeneticsUnfolded protein responseEndoplasmic reticulumGene

Abstract

fetched live from OpenAlex

INTRODUCTION: Alport Syndrome is a severe inherited glomerulopathy caused by pathogenic variants in genes encoding collagen-IV, the most abundant component of the glomerular basement membrane. Patients with Alport lack effective therapies beyond blockade of the renin-angiotensin-aldosterone system. Here, we test 4-phenylbutyrate (4-PBA) and tauroursodeoxycholic acid (TUDCA), two chemical chaperones, to rescue mouse models of a later-onset Alport Syndrome. METHODS: Knock-in mice bearing the Col4a3:p.Gly1332Glu pathogenic substitution in homozygosity and a compound heterozygous model bearing the same variant and the knockout allele were used. Mice received chaperones either for short or long-term periods. Also we examined the expression and secretion of mutant α3 chains in primary cultured mouse podocytes. RESULTS: TUDCA-treated Alport mice did not differ from the placebo-treated group. However, mice treated with 4-PBA demonstrated considerable improvement in the morphology and structure of glomerular basement membranes compared with control placebo-treated mice. Electron microscopy showed a 54% reduction of lesions and significant decline of lesion severity in the basement membrane of treated Alport mice. Additionally, treatment with 4-PBA reduced interstitial fibrosis, global and segmental glomerulosclerosis, while proteinuria and hematuria remained at low levels in Alport mice. In-vivo findings and in-vitro inhibition of the proteasome in primary cultured podocytes indicate that mutant collagen is reduced within the glomeruli of mutant mice, likely due to proteasomal degradation of misfolded collagen. Importantly, treatment of mice and cultured podocytes with 4-PBA improved secretion and incorporation of collagen IV into extracellular matrix probably by enhancing trimer folding. CONCLUSIONS: Our results suggest a therapeutic potential for 4-PBA in combating kidney dysfunction in Alport syndrome.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.003
Threshold uncertainty score0.010

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0010.000
Science and technology studies0.0000.001
Scholarly communication0.0010.000
Open science0.0010.000
Research integrity0.0010.002
Insufficient payload (model declined to judge)0.0030.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.018
GPT teacher head0.284
Teacher spread0.265 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations4
Published2025
Admission routes1
Has abstractno

Explore more

Same venueKidney InternationalSame topicCell Adhesion Molecules ResearchFrench-language works237,207